arginyl-glycyl-aspartyl-serine has been researched along with Neonatal Alloimmune Thrombocytopenia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dusseaux, M; Jallu, V; Kaplan, C | 1 |
1 other study(ies) available for arginyl-glycyl-aspartyl-serine and Neonatal Alloimmune Thrombocytopenia
Article | Year |
---|---|
A new Ser472Asn (Cab2(a+)) polymorphism localized within the αIIb "thigh" domain is involved in neonatal thrombocytopenia.
Topics: Adult; Amino Acid Substitution; Animals; Antibodies, Monoclonal; CHO Cells; Cricetinae; Cricetulus; Diseases in Twins; Epitopes; Female; Fibrinogen; Heterozygote; Humans; Immunity, Maternally-Acquired; Infant, Newborn; Integrin beta3; Male; Oligopeptides; Platelet Adhesiveness; Platelet Membrane Glycoprotein IIb; Polymorphism, Single Nucleotide; Protein Interaction Mapping; Structure-Activity Relationship; Thrombocytopenia, Neonatal Alloimmune; Transfection | 2011 |